Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$12.21 - $16.99 $503,052 - $699,987
-41,200 Reduced 67.32%
20,000 $294,000
Q1 2020

May 15, 2020

SELL
$9.03 - $19.72 $156,219 - $341,156
-17,300 Reduced 22.04%
61,200 $819,000
Q4 2019

Feb 14, 2020

SELL
$13.01 - $17.15 $244,588 - $322,420
-18,800 Reduced 19.32%
78,500 $1.11 Million
Q3 2019

Nov 14, 2019

BUY
$14.55 - $20.56 $760,965 - $1.08 Million
52,300 Added 116.22%
97,300 $1.59 Million
Q2 2019

Aug 14, 2019

BUY
$15.0 - $19.62 $300,000 - $392,400
20,000 Added 80.0%
45,000 $706,000
Q1 2019

May 15, 2019

BUY
$11.65 - $17.72 $291,250 - $443,000
25,000 New
25,000 $435,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $712M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.